Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia
- 1 October 2008
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 7 (10), 965-974
- https://doi.org/10.1016/s1474-4422(08)70194-7
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Gene expression study on peripheral blood identifies progranulin mutationsAnnals of Neurology, 2008
- TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysisThe Lancet Neurology, 2008
- TDP‐43 A315T mutation in familial motor neuron diseaseAnnals of Neurology, 2008
- Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementiaAmerican Journal of Medical Genetics Part A, 2008
- Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementiaHuman Mutation, 2008
- Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar DegenerationActa Neuropathologica, 2007
- TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseAnnals of Neurology, 2007
- Voxel-Based Morphometry in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With and Without Progranulin MutationsArchives of Neurology, 2007
- Characteristics of frontotemporal dementia patients with a Progranulin mutationAnnals of Neurology, 2006
- HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin‐positive, tau‐negative inclusions caused by a missense mutation in the signal peptide of progranulinAnnals of Neurology, 2006